{"nct_id":"NCT06926920","title":"A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-04-30","start_date_type":"ACTUAL","primary_completion_date":"2028-06","primary_completion_date_type":"ESTIMATED","completion_date":"2028-06","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["GILD"]}